CD4 count at the time of diagnosis

Major causes of death (%)

<50

50 - 199

200 - 349

350+

p-value

Tuberculosis (n = 102)

24.5

66.7

8.8

0.0

.005

Multiple infections (n = 34)

55.9

32.4

8.8

2.9

Wasting syndrome (n = 33)

48.5

36.4

15.2

0.0

Other specified conditions (n = 19)

31.6

36.8

31.6

0.0

AIDS related complex (n = 38)

44.7

50.0

5.3

0.0

Cause unknown (n = 84)

33.3

52.4

10.7

3.6

Others (n = 51)

27.5

52.9

15.7

3.9

WHO clinical stage at the start of ART

Major causes of death (%)

Stage 1

Stage 2

Stage 3

Stage 4

p-value

Tuberculosis (n = 105)

2.9

2.9

34.9

59.3

.000

Multiple infections (n = 34)

16.1

9.6

35.5

38.8

Wasting syndrome (n = 34)

39.3

15.1

33.4

12.2

Other specified conditions (n = 19)

22.2

5.6

55.6

16.6

AIDS related complex (n = 39)

25.0

11.1

36.2

27.7

Cause unknown (n = 87)

11.7

7.1

31.7

49.5

Others (n = 52)

24.0

22.0

36.0

18.0

Presence of OIs during treatment

Major causes of death (%)

Tuberculosis

Candidiasis

Multiple OIs

Others^*

p-value

Tuberculosis (n = 105)

81.9

3.8

11.4

2.9

.000

Multiple infections (n = 34)

11.8

23.5

35.3

29.4

Wasting syndrome (n = 34)

14.7

29.4

11.8

44.1

Other specified conditions (n = 19)

36.8

15.8

21.1

26.3

AIDS related complex (n = 39)

17.9

33.3

10.3

38.5

Cause unknown (n = 87)

34.5

20.7

12.6

32.2

Others (n = 52)

13.5

26.9

13.5

46.2

ART adherence during last follow-up

Major causes of death (%)

Adherence > 95%

Adherence <= 95%

p-value

Tuberculosis (n = 84)

50.0

50.0

.000

Multiple infections (n = 32)

68.7

31.3

Wasting syndrome (n = 34)

64.7

35.3

Other specified conditions (n = 19)

63.2

36.8

AIDS related complex (n = 38)

63.1

36.9

Cause unknown (n = 57)

49.1

50.9

Others (n = 50)

64.0

36.0